Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
AUTOR(ES)
Flågeng, M Hauglid
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2768454Documentos Relacionados
- Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
- Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
- Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
- Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer? -A prospective clinical study
- Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status